Skip to main content
. 2017 Jun 27;8(53):90905–90915. doi: 10.18632/oncotarget.18677

Figure 1. Andrographolide synergistically enhanced the anti-tumor effects of As2O3 on HepG2 cells.

Figure 1

(A) HepG2 cells were treated with andrographolide from 100 to 1600 nM for 48 h. The growth inhibition rate was measured by MTT assay. (B) The cells were treated with As2O3 or As2O3 plus andrographolide at indicated time point. (C) The cells were treated with indicated treatment for 48 h and morphological changes were visualized using a light microscope at 200 × magnification. Each experiment was repeated independently more than three times.